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Acute expression of the human papillomavirus E7 oncoprotein in preimmortal human fibroblasts induces changes in the
abundances of multiple cellular regulatory proteins. These alterations include a destabilization of the retinoblastoma tumor
suppressor protein pRB, stabilization of the tumor suppressor protein p53, and increases in the level of the cyclin-dependent
kinase inhibitor p21cip1. Since the HPV E7 oncoproteins can interfere with several cell cycle checkpoints and similar
alterations in the levels of pRB, p53, and p21cip1 are also observed in a p53-dependent response to DNA damage, we
investigated whether E7 expression triggers this signal transduction pathway. The results demonstrate that E7-mediated
destabilization of pRB does not require p53 activity and is independent of the ability of E7 to induce apoptosis. Moreover,
E7-mediated increases in p21cip1 levels are largely p53-independent and involve stabilization of the p21cip1 protein. In contrast
the decreases in pRB expression in response to DNA damage involve transcriptional downregulation of RB gene expression.
© 1999 Academic Press
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tINTRODUCTION
The human papillomaviruses (HPVs) are small DNA-
ontaining viruses which exhibit a specific tropism for
pithelial cells. Infection with these viruses leads to the
ormation of mostly benign epithelial hyperplasias, com-
only known as warts. A subset of the approximately 100
haracterized HPVs are specifically associated with le-
ions of the anogenital tract. They are further classified
s the “low-risk” HPVs (such as HPV-6 and HPV-11),
hich are most often associated with lesions with a low
ntrinsic propensity for carcinogenic progression, and
he “high-risk” types (such as HPV-16 and HPV-18), which
re associated with squamous intraepithelial lesions
SILs) of the uterine cervix which have a higher incidence
f progression to cervical carcinoma. More than 90% of
uman cervical cancers have been shown to harbor
igh-risk HPV DNA (reviewed by zur Hausen, 1996).
The high-risk HPVs encode two oncoproteins, E6 and
7, which are consistently expressed in HPV-positive
ervical cancers. Expression of these two viral genes is
equired for immortalization of primary human genital
pithelial cells. Moreover, continued expression of E6
nd E7 is necessary for the maintenance of the trans-
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Pathology and Center for Cancer Biology,
arvard Medical School, 200 Longwood Avenue, Goldenson Building,
oom 113A, Boston, MA 02115-5701. Fax: 617 432 0426. E-mail:tarl_munger@hms.harvard.edu.
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406ormed state. Both E6 and E7 bind to and inactivate
ellular regulatory proteins, including the p53 and reti-
oblastoma (pRB) tumor suppressor proteins, respec-
ively (reviewed by Howley, 1996). Expression of the HPV
7 protein results in a decrease of the half life of pRB
Boyer et al., 1996; Jones and Mu¨nger, 1997). One of the
mportant activities of pRB is to regulate the transcrip-
ional activity of members of the E2F family of transcrip-
ion factors, which have been recognized as critical reg-
lators of the G1/S transition in the cell division cycle. In
he G1 phase of the cell cycle, hypophosphorylated pRB
an form complexes with E2F family members. The pRB/
2F complexes act as transcriptional repressors that
egatively regulate genes required for S-phase progres-
ion, thereby blocking G1/S transit. Near the restriction
oint in late G1, pRB is phosphorylated, resulting in the
isruption of the E2F/pRB repressor complexes. When
ot bound to pRB, E2F functions as a transcriptional
ctivator, leading to enhanced transcription of S-phase-
pecific genes (reviewed by Weinberg, 1995). Due to the
nactivation of pRB in HPV E7-expressing cells, there is a
ower abundance of E2F/pRB repressor complexes
Chellappan et al., 1992; Pagano et al., 1992), contributing
o deregulated cell cycle control. Therefore, HPV E7-
ediated inactivation of pRB is an important mechanism
y which E7 contributes to cellular immortalization and
ransformation (reviewed by Jones and Mu¨nger, 1996).
onsistent with this model, we have recently reported
hat the ability of HPV E7 to destabilize pRB correlates
ightly with cellular transformation in that HPV-16 E7
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407HPV E7 AND CELLULAR DNA DAMAGE RESPONSEutants that are unable to transform cells also lack to
bility to destabilize pRB and, similarly, the low-risk
PV-6 E7 protein does not efficiently induce pRB desta-
ilization (Jones et al., 1997b).
In addition to pRB destabilization, expression of
PV-16 E7 induces increases in the steady-state levels
f several cellular proteins, including the p53 tumor sup-
ressor protein (Demers et al., 1994a; Jones and Mu¨nger,
997) and the cyclin-dependent kinase (Cdk) inhibitor
21cip1 (Jones et al., 1997a). Increases in the levels of
hese proteins have been shown to be a functionally
elevant hallmark of the response that normal cells can
ount as a consequence of DNA damage. It has been
learly documented that expression of HPV-16 E7 inter-
eres with G1/S (Vousden et al., 1993; Demers et al.,
994b; Slebos et al., 1994) and G2/M (Thomas and
aimins, 1998) checkpoints, thereby causing accumula-
ion of genetic aberrations (White et al., 1994). Therefore,
e wanted to determine whether the observed changes
n pRB, p53, and p21cip1 by E7 were a consequence of the
bility of E7 to evoke a p53-dependent cellular DNA
amage response or whether E7 expression may mimic
uch a pathway.
RESULTS
7-mediated induction of p21cip1 is independent of
53 activity
Normal human cells that express the HPV-16 E7 on-
oprotein contain increased levels of p53 as well as
21cip1. Since p21cip1 is a transcriptional target of p53
El-Deiry et al., 1993,1994), one might assume that in-
reased p21cip1 levels in E7-expressing cells are due to
ranscriptional induction by p53. Therefore, we first in-
estigated if p53 activity is required for the upregulation
f p21cip1 in response to E7 expression. We generated
opulations of IMR-90 cells expressing either the HPV-16
6 protein (which targets p53 for rapid degradation)
Scheffner et al., 1990) or one of two dominant negative
ersions (the V143A point mutant or a carboxyl terminal
inigene) of p53 using a series of LXSN-based retroviral
ectors which confer neomycin resistance. To obtain
7-expressing cells, G418-resistant cell populations de-
ived from each of these experiments were infected with
n HPV-16 E7-encoding pBABE-based retrovirus which
onfers puromycin resistance. E7-expressing cells were
elected in puromycin and pooled populations were
sed for further analysis. Extracts were prepared from
ach of the different cell populations, and the steady-
tate levels of p53 and p21cip1 were analyzed (Fig. 1). As
xpected, expression of HPV-16 E6 resulted in a dra-
atic reduction of p53 levels, while expression of the
ominant negative p53 mutants resulted in increased
evels of p53 (Fig. 1; top panel). This reflects the ability of
utant p53 to interact with the wild-type form and de-
osit it in inactive complexes (reviewed by Levine, 1997). tonsistent with inactivation of p53 function by each of
hese expressed proteins, p21cip1 levels were decreased
ompared to control virus-infected cells. The most dra-
atic reduction in p21cip1 levels was observed in cell
opulations expressing HPV-16 E6 and those harboring
he carboxyl terminal p53 fragment, while the decrease
n p21cip1 levels was less pronounced in cells that ex-
ressed the V143A p53 mutant (Fig. 1; top panel). This
ikely reflects the ability of HPV-16 E6 and the carboxyl
erminal p53 fragment to more efficiently inactivate p53
unction than the V143A mutant (Scheffner et al., 1990;
ottlieb et al., 1994). The observed decreases in p21cip1
evels are consistent with a recent report that has shown
hat constitutive levels of p21cip1 expression are regulated
y p53 (Tang et al., 1998). Expression of E7 in each of the
ell pools resulted in increased p21cip1 levels (Fig. 1;
ottom panel). This result clearly illustrates that p53
ctivity is not strictly required for the E7-mediated in-
reases in p21cip1 protein levels. The E7-mediated in-
rease of p21cip1 in the E6-expressing cells is minimal,
ut has been observed in multiple independent experi-
ents. Therefore, the increased levels of p21cip1 detected
n E7-expressing cells are not a mere consequence of
7-mediated stabilization of p53.
PV-16 E7 expression leads to the stabilization of
21cip1
Since E7 can increase p21cip1 levels independently of
53 function, we analyzed whether the E7-mediated in-
rease in p21cip1 levels was by a transcriptional mecha-
ism. Northern blot analysis of E7-expressing and con-
rol IMR-90 cells revealed a 50% increase of p21cip1
RNA in the E7-expressing populations (Fig. 2A; left
anel). In contrast, there was a 200% increase of p21cip1
RNA levels in response to DNA damage in these cells
Fig. 2A, right panel). Next we directly compared the
ncreases in p53 and p21cip1 protein levels in these cells
n response to DNA damage and E7 expression. The
bserved increases in p53 and p21cip1 were indistin-
uishable (Fig. 2B). Combined with the results shown in
ig. 2A, these results suggest that there must be non-
FIG. 1. E7-mediated induction of p21cip1 is independent of p53 activity.
MR-90 cells expressing HPV-16 E6 (16E6), a dominant negative point
utant of human p53 (V143A), or a carboxyl terminal fragment of the
urine p53 (p53-C) were infected with a recombinant retrovirus encod-
ng HPV-16 E7 (pBABE-16E7). Steady-state levels of p53 (top) and p21cip1
bottom) were analyzed by immunoblot analysis of cell extracts (100
g).ranscriptional mechanisms that contribute to the in-
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408 JONES ET AL.reases in p21cip1 levels in E7-expressing cells. There-
ore, we compared the half life of the intracellular pool of
he p21cip1 protein in E7-expressing and control cells.
xponentially growing cultures of E7-expressing and
ontrol cells were treated with cycloheximide to extin-
uish de novo protein synthesis, and the half life of
21cip1 was determined by immunoblot analysis. In the
ontrol cells, the p21cip1 protein had a half life of less than
0 min. In contrast, however, the half life of p21cip1 was
ncreased to 90 to 120 min in the E7-expressing cell
opulation (Fig. 2C).
ecreases in pRB levels in response to E7
xpression are independent of p53 activity
The ability of E7 to destabilize pRB tightly correlates its
FIG. 2. Comparison of p21cip1 induction by E7 expression and in
esponse to DNA damage. (A) Northern blot analysis of p21cip1 mRNA
evels. RNA was isolated from IMR-90 human diploid fibroblasts that
ad been infected with empty vector (LXSN) or with a recombinant
etrovirus expressing HPV-16 E7 (LXSN-16E7) (left panel) or from
MR-90 cells treated without (2) or with (1) 2.5 nM actinomycin D for
2 h to inflict DNA damage (right panel). Total cellular RNA (5 mg) was
ize fractionated on a 1% agarose–MOPS/formaldehyde gel and trans-
erred to a nylon membrane. A human p21cip1 cDNA was used as a
robe. Hybridization using a fragment of the glyceraldehyde-3-phos-
hate dehydrogenase (GAPDH) gene was included as a loading con-
rol. A quantitation of the signals after normalization for equal loading
s shown underneath. (B) Immunoblot analysis of p53 (top) and p21cip1
bottom) of control IMR-90 cells treated without (2) or with (1) 2.5 nM
ctinomycin for 48 h or infected with empty vector (LXSN) or a retro-
irual vector expressing HPV-16 E7 (LXSN-16E7). After SDS–PAGE,
roteins were electroblotted, the membrane was cut in half, and the
pper and lower halves were probed with monoclonal antibodies
pecific for p53 and p21cip1, respectively. The two halves were reas-
embled and exposed to the same piece of film. (C) Half life analysis of
21cip1 in control (LXSN) and HPV-16 E7-(LXSN-16E7) expressing
MR-90 cells. Cells were treated with 20 mg/ml cycloheximide for times
ndicated and harvested. Steady-state levels of p21cip1 were determined
y analyzing protein extracts (100 mg) by SDS–PAGE and immunoblot-
ing.bility to stabilize p53, in that every E7 mutant that is able bo destabilize pRB can also stabilize p53 and vice versa
Jones et al., 1997b). Therefore, we analyzed whether p53
unction was necessary for decreases in pRB levels in
esponse to HPV-16 E7 expression. A set of IMR-90 cells
xpressing HPV-16 E6 or dominant negative versions of
53 were infected with a pBABE-based retrovirus encod-
ng HPV-16 E7. The steady-state level of pRB was ana-
yzed by immunoblotting and was decreased in each cell
opulation in response to E7 expression (Fig. 3). Inter-
stingly, there was a selective decrease of hypophos-
horylated pRB, with the remaining pRB being mostly
yperphosphorylated, in the E7-expressing cells. This is
onsistent with previous observations (Boyer et al., 1996;
erezutskaya and Bagchi, 1997; Jones and Mu¨nger, 1997)
nd reflects the ability of HPV-16 E7 to preferentially
nteract with (Dyson et al., 1992) and destabilize (Boyer et
l., 1996) the hypophosphorylated form of pRB. These
esults show that decreases in pRB levels in response to
7 expression are mediated by a p53-independent
echanism.
ecreases in pRB levels in response to DNA damage
nvolve transcriptional regulation
It has been previously recognized that the steady-state
evels of pRB decrease not only upon expression of E7
ut also after p53-mediated DNA damage (Demers et al.,
994b; Jones and Mu¨nger, 1997). The decrease in pRB
evels in response to E7 expression is largely due a
ecrease in protein stability, while the mRNA levels re-
ain unaltered (Boyer et al., 1996; Jones and Mu¨nger,
997). Therefore we wanted to determine whether the
ecrease in pRB levels during DNA damage was due to
transcriptional or a nontranscriptional mechanism.
ormal human diploid IMR-90 fibroblasts were treated
ith 2.5 nM actinomycin D to inflict DNA damage. Immu-
oblot analysis revealed gradual dephosphorylation and
concomitant decrease in steady-state levels of pRB
Fig. 4; top panel). Analysis of RB mRNA by Northern
lotting revealed that these decreases of pRB protein
ere paralleled by decreases in RB mRNA levels (Fig. 4;
iddle panel). These results sharply contrast the finding
hat RB mRNA levels are unchanged in E7-expressing
ells (Boyer et al., 1996; Jones and Mu¨nger, 1997) and
urther support the notion that expression of E7 does not
FIG. 3. Decreases in pRB levels in response to E7 expression are
ndependent of p53 activity. IMR-90 cells expressing HPV-16 E6 (16E6),
dominant negative point mutant of human p53 (V143A), or a carboxyl
erminal fragment of the murine p53 (p53-C) were infected with a
ecombinant retrovirus encoding HPV-16 E7 (pBABE-16E7). The steady-
tate levels of pRB were determined by analyzing cell extracts (100 mg)
y SDS–PAGE and immunoblotting.
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409HPV E7 AND CELLULAR DNA DAMAGE RESPONSErigger a p53-dependent DNA damage response path-
ay.
7-mediated destabilization of pRB is not a
onsequence of its ability to predispose cells
o undergo apoptosis
It has been suggested that pRB is a substrate for
aspases and is cleaved during apoptosis (reviewed by
an and Wang, 1998). Since it has been shown that E7
an predispose IMR-90 cells to undergo apoptosis in
esponse to conflicting growth signals and because de-
reases in pRB levels have been associated with an
ncreased propensity to undergo apoptosis (Almasan et
l., 1995; Haaskogan et al., 1995; Haupt et al., 1995;
acleod et al., 1996), we determined whether pRB levels
ere further decreased in E7-expressing cells that are
ndergoing apoptosis and whether inhibition of apopto-
is by the caspase inhibitor Z-VAD-FMK in E7-expressing
ells would result in increased pRB levels. Cells express-
ng E7 or control cells were exposed to low serum
onditions for 56 h and were then exposed to the
aspase inhibitor Z-VAD-FMK for an additional 12 h. Cells
ere stained with Hoechst dye and analyzed by fluores-
ence microscopy to identify apoptotic cells by charac-
eristic changes in nuclear morphology. Analysis of pRB
y immunoblot analysis revealed several important
oints. In contrast to the control cells, there was no
ephosphorylation of pRB in E7-expressing cells in re-
ponse to serum deprivation (Fig. 5; lanes 1, 3, 5, and 7)
nd treatment of E7-expressing cells with caspase inhib-
tor resulted in a reduction of hyperphosphorylated pRB
oncomitant with decreased apoptosis (Fig. 5; lanes
–8). These findings are consistent with our model that
he ability of E7 to predispose cells to undergo apoptosis
FIG. 4. Decreases in pRB levels in response to DNA damage involve
ranscriptional regulation. IMR-90 cells were treated with 2.5 nM acti-
omycin D (Act. D) at the times indicated and cell extracts were
repared and total RNA was isolated. pRB levels were determined by
DS–PAGE and immunoblot analysis of 100 mg cell extracts (top). RB
RNA levels were determined by size fractionation of RNA (5 mg) on a
% agarose–MOPS/formaldehyde gel and capillary transfer to a nylon
embrane. A fragment of the human RB cDNA was used as a hybrid-
zation probe (middle panel). Hybridization using a fragment of the
APDH gene was included as a loading control (bottom panel).s linked to its growth promoting activity, which in the sbsence of other growth signals (such as serum compo-
ents) triggers an apoptosis pathway (Jones et al.,
997b). This analysis also showed that the ability of E7 to
estabilize pRB is independent of the extent of apoptosis
n the culture (Fig. 5; lanes 5 and 7), and the levels of pRB
n Z-VAD-FMK-treated cells did not increase as a result of
nhibition of apoptosis (Fig. 5; lanes 5–8).
DISCUSSION
An immediate response to cellular insults, including
NA damage, in normal cells is the activation of the p53
umor suppressor protein, which in turn orchestrates a
ellular defense. In most cases, p53 activation involves
ncreases in the steady-state level of p53, due at least in
art to an increase in protein stability, although it likely
lso induces posttranslational modification of the protein
Gu and Roeder, 1997; Shieh et al., 1997). Many of the
ownstream events of p53 activation, in particularly
hose leading to a growth arrest in the G1 phase of the
ell division cycle, have been quite well elucidated and
epend on the transcriptional activity of p53 (reviewed by
evine, 1997). An important transcriptional target of p53
s the p21cip1 inhibitor of cyclin-dependent kinases (El-
eiry et al., 1993; Harper et al., 1993), and several studies
ave indicated that this protein is a major mediator of
53-induced G1 growth arrest (Deng et al., 1995). In
esponse to enhanced intracellular p53 activity, there is a
ranscriptional induction of p21cip1 mRNA expression ac-
ompanied by an increase in p21cip1 protein levels (El-
eiry et al., 1993). This Cdk inhibitory protein then asso-
FIG. 5. E7-mediated destabilization of pRB is independent of its
bility to predispose cells to apoptosis. IMR-90 cells expressing
PV-16 E7 (16 E7) or control cells (LXSN) were plated into medium
ontaining 10% serum. After 24 h, the medium was removed and
eplaced with medium containing 0.1% serum. After 56 h, 100 mM
-VAD-FMK was added into the media, and the cells were harvested
2 h later. Either matched sets of cells were fixed in methanol vapors
or Hoechst staining and quantitation of apoptotic cells (top panel) or
ell extracts were prepared for immunoblot analysis of pRB and p53
bottom panel). The results shown are from the same experiment;
imilar results were obtained in multiple experiments.
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410 JONES ET AL.iates with cyclin/Cdk complexes and inhibits their en-
ymatic activities (Harper et al., 1993). Critical substrates,
ncluding pRB, accumulate in their hypophosphorylated
tates, and cell cycle arrest ensues.
Similar alterations in the intracellular levels of p53 and
21cip1 also occur in response to acute expression of
PV-16 E7 in cells (Fig. 1). Expression of the high-risk
PV E7 oncoprotein decreases the vigilance of multiple
ell cycle checkpoints (Vousden et al., 1993; Demers et
l., 1994b; Slebos et al., 1994; Thomas et al., 1998), which
eads to the accumulation of genetic aberrations (White
t al., 1994). Hence we wanted to determine if expression
f E7 in normal, diploid cells triggers a p53-dependent
NA damage signal transduction pathway. Our results,
owever, suggest that while similar molecular changes
ccur in cells in response to DNA damaging signals and
7 expression, these changes are mediated by different
athways. While p53 and p21cip1 protein levels are in-
uced to similar levels by DNA damage and E7 expres-
ion (Fig. 2B), there are marked differences in p21cip1
RNA induction (Fig. 2A). In contrast to DNA damage
Fig. 2A, right panel) there is only a minimal transcrip-
ional induction of p21cip1 mRNA in response to E7 ex-
ression (Fig. 2A; left panel). However, we observed a
arked stabilization of the p21cip1 protein in E7-express-
ng cells. Therefore we suggest that the increases in
21cip1 protein in E7-expressing cells are at least in part
ue to stabilization of the protein in these cells (Figs. 1
nd 2). Consistent with this model, a comparison of
21cip1 mRNA and protein levels in E7-expressing kera-
inocytes has also suggested that p21cip1 levels are in-
reased by nontranscriptional mechanisms (Jian et al.,
998). It has been shown that p21cip1 is a substrate for
biquitin-mediated degradation through the 26S protea-
ome but its half life and its ubiquitination status remain
naffected by DNA damaging agents such as g and UV
rradiation (Maki and Howley, 1997). It is an intriguing
ossibility that the alteration of p21cip1 levels reflects the
bility of E7 to interact with p21cip1-containing complexes
Funk et al., 1997; Jones et al., 1997a). Consistent with
his idea, it has been found that the half life of p21cip1 is
ffected by binding to cellular targets, such as cyclin/Cdk
omplexes or PCNA (Cayrol and Ducommun, 1998).
oreover, alterations in p21cip1 levels during keratinocyte
ifferentiation are also modulated by both transcriptional
nd nontranscriptional mechanisms (Macleod et al.,
995; Alani et al., 1998).
Our results also suggest the interesting possibility that
7 expression does not as efficiently activate the tran-
criptional activation potential of p53 as DNA damage, at
east with respect to p21cip1 transcription (Figs. 2A and
B). The ability of E7 to increase p21cip1 levels indepen-
ently of p53 activity is further supported by the obser-
ations that p21cip1 levels increase in response to E7
xpression even when p53 activity is abrogated by the
xpression of HPV-16 E6 or expression of dominant neg- Stive versions of p53 (Fig. 1). Since HPV-16 E7 can over-
ome a p21cip1-mediated G1 growth arrest (Funk et al.,
997; Jones et al., 1997a), the cells continue to proliferate
n the presence of high levels of p21cip1. Moreover, the
ecreased levels of pRB in response to E7 expression
re due to a decreased stability of the protein (Boyer et
l., 1996; Jones and Mu¨nger, 1997), whereas in response
o DNA damage pRB levels are reduced due to de-
reased transcription of the RB gene (Fig. 4). Since DNA
amage results in G1 growth arrest in normal cells,
ecreased RB gene expression is predicted as expres-
ion of RB is negatively autoregulated through E2F-1
Shan et al., 1994).
While expression of the HPV E7 oncoprotein in normal
ells leads to life span extension and in some cell types
an cause immortalization (Halbert et al., 1991; Wazer et
l., 1995), it predisposes cells to undergo apoptosis
hen they are grown under conditions of growth factor
eprivation or when they are contact-inhibited (Jones et
l., 1997b). One of the defining hallmarks of apoptosis is
he activation of a cascade of cysteine proteases,
aspases, which are responsible for the cleavage of
ritical substrates, including proteins of the nuclear lam-
na, cytoskeleton, and nucleus (reviewed by Cryns and
uan, 1998). Interestingly, pRB has also been shown to
e a substrate of caspases and is cleaved during apo-
tosis (An and Dou, 1996; Janicke et al., 1996). Since it
as been proposed that pRB cleavage mechanistically
ontributes to programmed cell death (reviewed in Tan
nd Wang, 1998), we determined whether E7-mediated
RB destabilization may reflect the ability of E7 to pre-
ispose cells to undergo apoptosis in response to
rowth arrest signals. We had previously shown that
reatment of normal and E7-expressing cells with the
aspase inhibitor YVAD caused a minor increase in the
evels of pRB, suggesting that caspases do not play a
pecific role in E7-mediated apoptosis (Jones and
u¨nger, 1997). Here we show that E7-mediated pRB
estabilization is observed regardless of whether the
ells undergo apoptosis (Fig. 5), demonstrating that the
oss of RB is upstream of the ability of E7 to induce
poptosis.
We have yet to determine the cellular factors required
or E7-mediated pRB destabilization; however, we have
ocumented a striking correlation between the destabi-
ization of pRB in E7-expressing cells and the stabiliza-
ion of p53. Although, we have seen that pRB destabili-
ation is not dependent on the stabilization of p53, the
ependence of p53 stabilization on pRB loss or inactiva-
ion has not been dissociated. Increases in p53 levels
ave been seen in response to expression of other viral
ncoproteins, including Ad E1A and SV40 TAg. E1A-
nduced stabilization of p53 protein has been shown to
e dependent on the ability of E1A to bind to the tran-
criptional coactivator p300 (Chiou and White, 1997;
amuelson and Lowe, 1997) and to pRB (Samuelson and
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411HPV E7 AND CELLULAR DNA DAMAGE RESPONSEowe, 1997). To date there is no evidence to suggest that
PV-16 E7 interacts with p300 (Davies and Vousden,
992). The protein encoded by the alternative open read-
ng frame of the ink4a tumor suppressor locus, p14ARF,
as been implicated in mediating p53 stabilization by Ad
1A and c-myc (de Stanchina et al., 1998; Zindy et al.,
998). The p14ARF protein binds to mdm2 and interferes
ith mdm2-mediated degradation of p53 (Haupt et al.,
997; Kubbutat et al., 1997; Stott et al., 1998; Zhang et al.,
998). We have previously shown that there is a precise
nverse correlation between the destabilization of pRB
nd stabilization of p53 in response to E7 expression
Jones et al., 1997b). Here we demonstrate that the ability
f E7 to affect the stability of pRB is independent of p53
ctivity (Fig. 3B) and hence pRB destabilization may be
he initiating event that causes p53 stabilization. Inacti-
ation of pRB by E7 results in activation of the transcrip-
ion factor E2F, and it has recently been shown that the
14ARF promoter can be activated by E2F (Bates et al.,
998). Therefore, it is a tantalizing possibility that p14ARF
ay mediate E7-triggered, pRB-mediated p53 stabiliza-
ion (Bates et al., 1998).
It may seem counterintuitive that E7 expression trig-
ers a cellular response so similar to a p53-dependent
NA damage signal. However, we propose that this
epresents what has been characterized as a “thrust and
arry” relationship between the host cell and the invad-
ng virus (Weinberg, 1997): the infected host cell can
ense the intruding virus and engages defense mecha-
isms that arrest cellular division or lead to cellular
uicide in an attempt to limit viral propagation. The virus,
owever, has developed strategies to undermine these
ellular defense signals in order to guarantee its survival
nd replication in the infected host cell. Since HPV-16 E7
an thwart p53-mediated growth arrest (Vousden et al.,
993; Demers et al., 1994b; Slebos et al., 1994) but not
poptosis signals (Wang et al., 1996), the main function of
6-mediated p53 degradation in such a scenario may be
o counteract the p53-mediated apoptotic response of
he infected host cell that is triggered by E7 expression
Jones et al., 1997b).
MATERIALS AND METHODS
ell culture
Low-passage, normal, diploid, human lung fibroblasts
IMR-90) were purchased from ATCC (Nichols et al.,
977). They were maintained in DMEM supplemented
ith 10% fetal bovine serum, 50 U/ml penicillin, and 50
g/ml streptomycin. Packaging cell lines (PA317) produc-
ng recombinant retroviruses LXSN, HPV-16 E6, and
PV-16 E7 were kindly provided by D. Galloway (Fred
utchinson Cancer Center, Seattle, WA) (Halbert et al.,
991), and packaging cell lines producing pBABEpuro-
ased retroviruses (Morgenstern and Land, 1990) encod-ng HPV-16 E7 were kindly provided by V. Band (Tufts aniversity Medical School, Boston, MA). Packaging cells
roducing the dominant negative version of p53, V143A,
ere kindly provided by Roger Pomerantz (Thomas Jef-
erson University, Philadelphia, PA). The carboxyl termi-
al fragment of the murine p53 (Gottlieb et al., 1994) was
btained from M. Oren (The Weizmann Institute of Sci-
nce, Rehovot, Israel) and was cloned into pLXSN (Miller
nd Rosman, 1989). PA317-derived packaging lines were
erived according to standard procedures and were
aintained in DMEM supplemented with 10% fetal bo-
ine serum, 50 U/ml penicillin, and 50 mg/ml streptomy-
in. Recombinant retroviruses were prepared using stan-
ard methods (Miller and Rosman, 1989). Infections of
MR-90 cells were performed by plating cells at approx-
mately 80% confluence in 10-cm plates. Medium was
emoved and replaced with 2 ml of viral supernatant and
ml of media containing 8 mg/ml polybrene (hexadimeth-
ene bromide; Sigma). After a 4-h incubation, the virus-
ontaining medium was replaced with normal medium.
fter 48 h, the cells were selected in 300 mg/ml G418
Geneticin; Gibco BRL) or 2.5 mg/ml puromycin (Sigma).
mmunological methods
Cell lysates for immunoprecipitation and immunoblot
nalysis of proteins were made by lysing IMR-90 cells in
.1% NP-40 lysis buffer (250 mM NaCl, 50 mM Tris–HCl
pH 7.5), 5 mM EDTA, 0.1% Nonidet P-40 (NP-40), pH 7.5,
mM dithiothreitol (DTT), 0.5 mM PMSF, 1 mg/ml apro-
inin and leupeptin, 2 mM NaF, 0.5 mM Na2VO3) for 30
in on ice. Cells were then scraped from the plates
sing a rubber policeman, and extracts were cleared by
entrifugation at 15,000g for 15 min. Protein concentra-
ions were determined using the Bradford method (Bio-
ad). For immunoblot analysis, 100 mg protein was used
or each sample. Samples were boiled in SDS-containing
ample buffer and separated by sodium dodecyl sulfate–
olyacrylamide gel electrophoresis (SDS–PAGE). Pro-
eins were transferred onto polyvinylidene difluoride
embranes (Immobilon P, Millipore). Membranes were
locked in TNET buffer (10 mM Tris HCl, 50 mM NaCl, 2.5
M EDTA, with 0.1% Tween 20, pH 7.5) containing 5%
onfat dry milk and probed with the appropriate antibody,
ccording to standard protocols. Enhanced chemilumi-
escence was used to detect antigen–antibody com-
lexes (ECL, Amersham). In cases where evaluation of
uantitative differences was necessary, short as well as
ong exposures were analyzed to ensure that the differ-
nces observed were within the linear range of the X-ray
ilm. Quantitations were performed by densitometric
canning and analysis using NIH Image software. The
ntibodies used were pRB (Ab-5; Oncogene Science),
53 (Ab-6; Oncogene Science), p21cip1 (CP-36; a gift from
. Dynlacht, Harvard University, Cambridge, MA—Zhu et
l., 1995).
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412 JONES ET AL.orthern blot analysis
Total RNA was isolated from IMR-90 cells by the one-
tep phenol/chloroform extraction method adapted from
homczynski and Sacchi (1987). RNA (5 mg) was size
ractionated on a 1% agarose–MOPS/formaldehyde gel
nd transferred to a nylon membrane (Hybond N, Amer-
ham), according to the manufacturer’s protocol.
rotein half-life determination
Cells were plated onto 60-mm dishes (1.4 3 106 cells/
ish). The cells were treated with 20 mg/ml cyclohexi-
ide (Actidione; Fluka) resuspended at a concentration
f 20 mg/ml in ethanol. For p21cip1 half life determination,
amples were taken at 0, 30, 60, 90, and 120 min. After
reatment, the cells were harvested and lysed in 0.1%
P-40 lysis buffer. Samples (100 mg) were analyzed by
DS–PAGE and immunoblotting as described above.
ctinomycin D treatment
DNA damage was initiated by treatment with 2.5 nM
ctinomycin D (Sigma) for up to 48 h. The cells were
reated at approximately 70% confluence. Afterward, the
ells were harvested and lysates were prepared for
mmunoblot analysis.
poptosis assays and caspase inhibitor treatment
IMR-90 cells expressing HPV-16 E7 or vector control
ells were plated onto 60-mm dishes at approximately
3 105 cells/dish. Twenty-four hours after plating, cells
ere placed into media containing 0.1% fetal bovine
erum. Fifty-six hours after plating, the cells were treated
ith the pan-caspase inhibitor Z-VAD-FMK (benzyloxy-
arbonyl-Val-Ala-Asp fluoromethylketone). Z-VAD-FMK
as purchased from Enzyme Systems Products, Inc.
Dublin, CA) and resuspended in DMSO at a concentra-
ion of 20 mM stock. Cells were treated with 100 mM
-VAD-FMK for 12 h after which time either the cells were
repared for apoptosis analysis or protein lysates were
repared for immunoblot analysis. Apoptotic nuclei were
dentified by characteristic changes in nuclear morphol-
gy as visualized by fluorescence microscopy of
oechst 33258-stained cells. In brief, cells were fixed by
xposure to methanol vapors for 10 min, followed by
mmersion in methanol for at least 10 min. Cells were
tained with 1 mg/ml bisbenzimide (Hoechst 33258,
igma) in 0.1% nonfat milk (Carnation) for 7 min and
insed in water. Stained cells were covered with a drop of
.1 M N-propyl gallate in 80% glycerol and analyzed by
luorescence microscopy. Approximately 400 cells were
ounted per data point. Matched sets of cells were also
arvested in 0.1% lysis buffer for immunoblot analysis as
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